Structures by: Aridoss G.
Total: 16
1-Bromoacetyl-2,6-bis(4-methoxyphenyl)-3,5-dimethylpiperidin-4-one
C23H26BrNO4
Acta Crystallographica Section E (2008) 64, 10 o2009-o2010
a=12.9487(9)Å b=25.2882(18)Å c=8.9701(6)Å
α=90.00° β=132.9300(10)° γ=90.00°
R-2,c-6-Bis(4-fluorophenyl)-t-3,t-5-dimethylpiperidin-4-one
C19H19F2NO
Acta Crystallographica Section E (2008) 64, 2 o429-o429
a=7.3830(6)Å b=24.0102(19)Å c=9.4278(7)Å
α=90.00° β=101.7270(10)° γ=90.00°
N-[4-Acetyl-5-(3-methoxyphenyl)-4,5-dihydro-1,3,4-thiadiazol-2-yl]acetamide
C13H15N3O3S
Acta Crystallographica Section E (2008) 64, 11 o2096
a=11.3790(4)Å b=10.5993(3)Å c=11.9596(2)Å
α=90.00° β=108.225(2)° γ=90.00°
<i>r</i>-2,<i>c</i>-6-Bis(2-methoxyphenyl)-<i>t</i>-3,<i>t</i>-5-dimethylpiperidin-4-one acetic acid solvate
C21H25NO3,C2H4O2
Acta Crystallographica Section E (2010) 66, 6 o1428
a=9.3059(5)Å b=10.7052(8)Å c=11.8950(7)Å
α=94.432(3)° β=93.341(2)° γ=109.502(3)°
1-(2-Bromoacetyl)-3-methyl-2,6-diphenylpiperidin-4-one
C20H20BrNO2
Acta Crystallographica Section E (2010) 66, 6 o1479
a=21.4006(8)Å b=14.5873(6)Å c=13.8107(5)Å
α=90.00° β=125.368(2)° γ=90.00°
Ethyl 1-benzoyl-4-hydroxy-2,6-diphenyl-1,2,5,6-tetrahydropyridine-3-carboxylate
C27H25NO4
Acta Crystallographica Section E (2011) 67, 3 o540
a=8.2784(7)Å b=10.6116(9)Å c=12.7572(11)Å
α=85.681(4)° β=89.963(4)° γ=82.508(5)°
Ethyl 1-(2-bromopropanoyl)-4-hydroxy-2,6-diphenyl-1,2,5,6-tetrahydropyridine-3- carboxylate
C23H24BrNO4
Acta Crystallographica Section E (2009) 65, 7 o1708-o1709
a=10.3970(4)Å b=14.4874(6)Å c=15.8580(7)Å
α=65.457(2)° β=89.556(3)° γ=80.597(3)°
1-Chloroacetyl-2,6-bis(3-fluorophenyl)piperidin-4-one
C19H16ClF2NO2
Acta Crystallographica Section E (2009) 65, 8 o1994-o1995
a=10.7026(8)Å b=8.2017(6)Å c=19.0447(15)Å
α=90.00° β=100.6290(10)° γ=90.00°
1-Chloroacetyl-2,6-bis(2-methoxyphenyl)-3,5-dimethylpiperidin-4-one
C23H26ClNO4
Acta Crystallographica Section E (2009) 65, 9 o2276-o2277
a=8.9921(6)Å b=11.3725(8)Å c=11.9373(8)Å
α=71.6300(10)° β=68.4650(10)° γ=72.9030(10)°
Ethyl 4-hydroxy-2,6-diphenyl-1-(2-thiomorpholinopropanoyl)- 1,2,5,6-tetrahydropyridine-3-carboxylate
C27H32N2O4S
Acta Crystallographica Section E (2009) 65, 12 o3180-o3181
a=9.904(3)Å b=11.400(4)Å c=12.103(4)Å
α=93.908(18)° β=104.941(15)° γ=106.819(16)°
Ethyl 4-hydroxy-1-(2-morpholinopropanoyl)-2,6-diphenyl- 1,2,5,6-tetrahydropyridin-3-carboxylate
C27H32N2O5
Acta Crystallographica Section E (2009) 65, 12 o3232-o3233
a=8.2251(2)Å b=10.6219(4)Å c=28.7046(10)Å
α=90.00° β=92.375(2)° γ=90.00°
Ethyl 4-(3-chlorophenyl)-3,6-dihydroxy-6-methyl-2-(2-pyridyl)-4,5,6,7- tetrahydroindazole-5-carboxylate
C22H22ClN3O4
Acta Crystallographica Section E (2010) 66, 4 o861
a=8.585(5)Å b=9.053(3)Å c=14.884(3)Å
α=94.68(2)° β=90.19(2)° γ=115.66(3)°
Ethyl 4-hydroxy-2,6-diphenyl-1-(2-thiomorpholinoacetyl)-1,2,5,6-tetrahydropyridine- 3-carboxylate
C26H30N2O4S
Acta Crystallographica Section E (2010) 66, 8 o1982
a=10.9561(6)Å b=9.5665(6)Å c=22.9011(12)Å
α=90.00° β=93.575(3)° γ=90.00°
Ethyl 4-hydroxy-2,6-diphenyl-1-[2-(piperidin-1-yl)acetyl]-1,2,5,6- tetrahydropyridine-3-carboxylate
C27H32N2O4
Acta Crystallographica Section E (2010) 66, 8 o2005
a=10.7936(6)Å b=9.6752(6)Å c=23.2335(13)Å
α=90.00° β=93.213(3)° γ=90.00°
Ethyl 1-[2-(1<i>H</i>-benzotriazol-1-yl)acetyl]-4-hydroxy-2,6-diphenyl- 1,2,5,6-tetrahydropyridine-3-carboxylate
C28H26N4O4
Acta Crystallographica Section E (2011) 67, 7 o1574
a=7.9214(2)Å b=21.9667(6)Å c=14.5621(4)Å
α=90.00° β=95.722(2)° γ=90.00°
Ethyl 1-[2-(1,3-benzoxazol-2-ylsulfanyl)acetyl]-4-hydroxy-2,6-diphenyl- 1,2,5,6-tetrahydropyridine-3-carboxylate
C29H26N2O5S
Acta Crystallographica Section E (2011) 67, 7 o1731
a=12.4630(2)Å b=24.3243(5)Å c=9.2350(2)Å
α=90.00° β=109.6080(10)° γ=90.00°